169 related articles for article (PubMed ID: 17972176)
21. Trends in breast cancer treatment in Connecticut.
Polednak AP; Flannery JT
Conn Med; 1993 Feb; 57(2):59-64. PubMed ID: 8449009
[TBL] [Abstract][Full Text] [Related]
22. Treatment and survival from breast cancer: the experience of patients at South Australian teaching hospitals between 1977 and 2003.
Luke C; Gill G; Birrell S; Humeniuk V; Borg M; Karapetis C; Koczwara B; Olver I; Penniment M; Pittman K; Price T; Walsh D; Yeoh EK; Roder D
J Eval Clin Pract; 2007 Apr; 13(2):212-20. PubMed ID: 17378867
[TBL] [Abstract][Full Text] [Related]
23. Impact of a positive family history on diagnosis, management, and survival of breast cancer: different effects across socio-economic groups.
Verkooijen HM; Rapiti E; Fioretta G; Vinh-Hung V; Keller J; Benhamou S; Vlastos G; Chappuis PO; Bouchardy C
Cancer Causes Control; 2009 Nov; 20(9):1689-96. PubMed ID: 19701688
[TBL] [Abstract][Full Text] [Related]
24. High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c.
Kyndi M; Overgaard M; Nielsen HM; Sørensen FB; Knudsen H; Overgaard J
Radiother Oncol; 2009 Jan; 90(1):74-9. PubMed ID: 18471914
[TBL] [Abstract][Full Text] [Related]
25. Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer.
Hoogendoorn WE; Hollema H; van Boven HH; Bergman E; de Leeuw-Mantel G; Platteel I; Fles R; Nederlof PM; Mourits MJ; van Leeuwen FE;
Breast Cancer Res Treat; 2008 Nov; 112(1):99-108. PubMed ID: 18064567
[TBL] [Abstract][Full Text] [Related]
26. Locoregional recurrence in breast carcinoma patients.
Yildirim E
Eur J Surg Oncol; 2009 Mar; 35(3):258-63. PubMed ID: 18644692
[TBL] [Abstract][Full Text] [Related]
27. Extended radical mastectomy versus simple mastectomy followed by radiotherapy in primary breast cancer. A fifty-year follow-up to the Copenhagen Breast Cancer randomised study.
Johansen H; Kaae S; Jensen MB; Mouridsen HT
Acta Oncol; 2008; 47(4):633-8. PubMed ID: 18465331
[TBL] [Abstract][Full Text] [Related]
28. Radiotherapy after segmental resection of breast cancer with favorable prognostic features: 12-year follow-up results of a randomized trial.
Holli K; Hietanen P; Saaristo R; Huhtala H; Hakama M; Joensuu H
J Clin Oncol; 2009 Feb; 27(6):927-32. PubMed ID: 19114687
[TBL] [Abstract][Full Text] [Related]
29. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM;
J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968
[TBL] [Abstract][Full Text] [Related]
30. Non-compliance with a postmastectomy radiotherapy guideline: decision tree and cause analysis.
Razavi AR; Gill H; Ahlfeldt H; Shahsavar N
BMC Med Inform Decis Mak; 2008 Sep; 8():41. PubMed ID: 18803875
[TBL] [Abstract][Full Text] [Related]
31. An update on prognosis in breast cancer patients with extensive axillary disease.
Hoehne F; Chen S; Mabry H; Giuliano AE
Breast J; 2008; 14(1):76-80. PubMed ID: 18086270
[TBL] [Abstract][Full Text] [Related]
32. Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation.
Haffty BG; Yang Q; Moran MS; Tan AR; Reiss M
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1006-13. PubMed ID: 18262731
[TBL] [Abstract][Full Text] [Related]
33. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
Schaapveld M; Visser O; Louwman MJ; de Vries EG; Willemse PH; Otter R; van der Graaf WT; Coebergh JW; van Leeuwen FE
J Clin Oncol; 2008 Mar; 26(8):1239-46. PubMed ID: 18323547
[TBL] [Abstract][Full Text] [Related]
34. Substantial increase in the use of adjuvant systemic treatment for early stage breast cancer reflects changes in guidelines in the period 1990-2006 in the southeastern Netherlands.
Sukel MP; van de Poll-Franse LV; Nieuwenhuijzen GA; Vreugdenhil G; Herings RM; Coebergh JW; Voogd AC
Eur J Cancer; 2008 Sep; 44(13):1846-54. PubMed ID: 18640030
[TBL] [Abstract][Full Text] [Related]
35. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
[TBL] [Abstract][Full Text] [Related]
36. DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy.
Sautter-Bihl ML; Budach W; Dunst J; Feyer P; Haase W; Harms W; Sedlmayer F; Souchon R; Wenz F; Sauer R; ;
Strahlenther Onkol; 2007 Dec; 183(12):661-6. PubMed ID: 18040609
[TBL] [Abstract][Full Text] [Related]
37. [Breast cancer prognosis in Salah Azaiez Institute of Cancer, Tunis].
Ben Gobrane H; Fakhfakh R; Rahal K; Ben Ayed F; Mâalej M; Ben Abdallah M; Achour N; Hsairi M
East Mediterr Health J; 2007; 13(2):309-18. PubMed ID: 17684853
[TBL] [Abstract][Full Text] [Related]
38. Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen.
Khoshnoud MR; Fornander T; Johansson H; Rutqvist LE
Breast Cancer Res Treat; 2008 Jan; 107(1):71-8. PubMed ID: 18043896
[TBL] [Abstract][Full Text] [Related]
39. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
40. Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
Dubsky P; Sevelda P; Jakesz R; Hausmaninger H; Samonigg H; Seifert M; Denison U; Mlineritsch B; Steger G; Kwasny W; Stöger H; Bartsch R; Stierer M; Taucher S; Fridrik M; Schippinger W; Greil R; Pötter R; Gnant M;
Clin Cancer Res; 2008 Apr; 14(7):2082-7. PubMed ID: 18381948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
